AMENDED AND RESTATED MANUFACTURING AND MARKETING LICENSE AGREEMENT between THE SECRETARY OF STATE FOR DEFENCE as represented by THE DEFENCE SCIENCE AND TECHNOLOGY LABORATORY (Dstl) and PHARMATHENE UK LTD. in respect of RECOMBINANT [***] VACCINEManufacturing and Marketing License Agreement • May 15th, 2009 • Pharmathene, Inc • Pharmaceutical preparations
THE SECRETARY OF STATE FOR DEFENCE acting through the Defence Science and Technology Laboratory [***] (hereinafter referred to as the “Licensor”) of the one part
FORM OF AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2009 • Pharmathene, Inc • Pharmaceutical preparations
This 1st AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective January 21, 2009 (the “Effective Date”) by and between David P. Wright (the “Executive”) and PharmAthene, Inc., a Delaware corporation (the “Company”).
CONSENT, ASSUMPTION AND SECOND LOAN MODIFICATION AGREEMENTLoan Modification Agreement • May 15th, 2009 • Pharmathene, Inc • Pharmaceutical preparations
This Consent, Assumption and Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of March 31, 2009, by and among SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 8020 Tower Crescent Drive, Suite 475, Vienna, Virginia 22182 (“SVB”), as agent (“Agent”), and the Lenders, SVB and OXFORD FINANCE CORPORATION (“Oxford”), and PHARMATHENE, INC. (“New Borrower”) (successor by merger with Pharmathene U.S. Corporation, a Delaware corporation, the “Existing Borrower”), a Delaware corporation with its chief executive office located at One Park Place, Suite #450, Annapolis, MD 21401.
PharmAthene, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] PRIVATE BETWEEN THE PARTIES AMENDED AND RESTATED LICENCE AGREEMENT between THE SECRETARY OF STATE...Licensing Agreement • May 15th, 2009 • Pharmathene, Inc • Pharmaceutical preparations
THE SECRETARY OF STATE FOR DEFENCE acting through the Defence Science and Technology Laboratory [***] the “Licensor”) of the one part
